Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model

R. Nicole Howie, Samuel Herberg, Emily Durham, Zachary Grey, Grace Bennfors, Mohammed Elsayed Elsalanty, Amanda C. LaRue, William D Hill, James J. Cray

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Bone wound healing is a highly dynamic and precisely controlled process through which damaged bone undergoes repair and complete regeneration. External factors can alter this process, leading to delayed or failed bone wound healing. The findings of recent studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs) can reduce bone mass, precipitate osteoporotic fractures and increase the rate of dental implant failure. With 10% of Americans prescribed antidepressants, the potential of SSRIs to impair bone healing may adversely affect millions of patients’ ability to heal after sustaining trauma. Here, we investigate the effect of the SSRI sertraline on bone healing through pre-treatment with (10 mg·kg-1 sertraline in drinking water, n = 26) or without (control, n = 30) SSRI followed by the creation of a 5-mm calvarial defect. Animals were randomized into three surgical groups: (a) empty/sham, (b) implanted with a DermaMatrix scaffold soak-loaded with sterile PBS or (c) DermaMatrix soak-loaded with 542.5 ng BMP2. SSRI exposure continued until sacrifice in the exposed groups at 4 weeks after surgery. Sertraline exposure resulted in decreased bone healing with significant decreases in trabecular thickness, trabecular number and osteoclast dysfunction while significantly increasing mature collagen fiber formation. These findings indicate that sertraline exposure can impair bone wound healing through disruption of bone repair and regeneration while promoting or defaulting to scar formation within the defect site.

Original languageEnglish (US)
Article number25
JournalInternational Journal of Oral Science
Volume10
Issue number3
DOIs
StatePublished - Sep 1 2018

Fingerprint

Sertraline
Serotonin Uptake Inhibitors
Bone and Bones
Wound Healing
Bone Regeneration
Osteoporotic Fractures
Dental Implants
Osteoclasts
Drinking Water
Antidepressive Agents
Cicatrix
Regeneration
Collagen
Wounds and Injuries

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model. / Howie, R. Nicole; Herberg, Samuel; Durham, Emily; Grey, Zachary; Bennfors, Grace; Elsalanty, Mohammed Elsayed; LaRue, Amanda C.; Hill, William D; Cray, James J.

In: International Journal of Oral Science, Vol. 10, No. 3, 25, 01.09.2018.

Research output: Contribution to journalArticle

Howie, R. Nicole ; Herberg, Samuel ; Durham, Emily ; Grey, Zachary ; Bennfors, Grace ; Elsalanty, Mohammed Elsayed ; LaRue, Amanda C. ; Hill, William D ; Cray, James J. / Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model. In: International Journal of Oral Science. 2018 ; Vol. 10, No. 3.
@article{374d15c104bc456ca348e0d4183adac7,
title = "Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model",
abstract = "Bone wound healing is a highly dynamic and precisely controlled process through which damaged bone undergoes repair and complete regeneration. External factors can alter this process, leading to delayed or failed bone wound healing. The findings of recent studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs) can reduce bone mass, precipitate osteoporotic fractures and increase the rate of dental implant failure. With 10{\%} of Americans prescribed antidepressants, the potential of SSRIs to impair bone healing may adversely affect millions of patients’ ability to heal after sustaining trauma. Here, we investigate the effect of the SSRI sertraline on bone healing through pre-treatment with (10 mg·kg-1 sertraline in drinking water, n = 26) or without (control, n = 30) SSRI followed by the creation of a 5-mm calvarial defect. Animals were randomized into three surgical groups: (a) empty/sham, (b) implanted with a DermaMatrix scaffold soak-loaded with sterile PBS or (c) DermaMatrix soak-loaded with 542.5 ng BMP2. SSRI exposure continued until sacrifice in the exposed groups at 4 weeks after surgery. Sertraline exposure resulted in decreased bone healing with significant decreases in trabecular thickness, trabecular number and osteoclast dysfunction while significantly increasing mature collagen fiber formation. These findings indicate that sertraline exposure can impair bone wound healing through disruption of bone repair and regeneration while promoting or defaulting to scar formation within the defect site.",
author = "Howie, {R. Nicole} and Samuel Herberg and Emily Durham and Zachary Grey and Grace Bennfors and Elsalanty, {Mohammed Elsayed} and LaRue, {Amanda C.} and Hill, {William D} and Cray, {James J.}",
year = "2018",
month = "9",
day = "1",
doi = "10.1038/s41368-018-0026-x",
language = "English (US)",
volume = "10",
journal = "International journal of oral science",
issn = "1674-2818",
publisher = "Sichuan University Press",
number = "3",

}

TY - JOUR

T1 - Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model

AU - Howie, R. Nicole

AU - Herberg, Samuel

AU - Durham, Emily

AU - Grey, Zachary

AU - Bennfors, Grace

AU - Elsalanty, Mohammed Elsayed

AU - LaRue, Amanda C.

AU - Hill, William D

AU - Cray, James J.

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Bone wound healing is a highly dynamic and precisely controlled process through which damaged bone undergoes repair and complete regeneration. External factors can alter this process, leading to delayed or failed bone wound healing. The findings of recent studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs) can reduce bone mass, precipitate osteoporotic fractures and increase the rate of dental implant failure. With 10% of Americans prescribed antidepressants, the potential of SSRIs to impair bone healing may adversely affect millions of patients’ ability to heal after sustaining trauma. Here, we investigate the effect of the SSRI sertraline on bone healing through pre-treatment with (10 mg·kg-1 sertraline in drinking water, n = 26) or without (control, n = 30) SSRI followed by the creation of a 5-mm calvarial defect. Animals were randomized into three surgical groups: (a) empty/sham, (b) implanted with a DermaMatrix scaffold soak-loaded with sterile PBS or (c) DermaMatrix soak-loaded with 542.5 ng BMP2. SSRI exposure continued until sacrifice in the exposed groups at 4 weeks after surgery. Sertraline exposure resulted in decreased bone healing with significant decreases in trabecular thickness, trabecular number and osteoclast dysfunction while significantly increasing mature collagen fiber formation. These findings indicate that sertraline exposure can impair bone wound healing through disruption of bone repair and regeneration while promoting or defaulting to scar formation within the defect site.

AB - Bone wound healing is a highly dynamic and precisely controlled process through which damaged bone undergoes repair and complete regeneration. External factors can alter this process, leading to delayed or failed bone wound healing. The findings of recent studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs) can reduce bone mass, precipitate osteoporotic fractures and increase the rate of dental implant failure. With 10% of Americans prescribed antidepressants, the potential of SSRIs to impair bone healing may adversely affect millions of patients’ ability to heal after sustaining trauma. Here, we investigate the effect of the SSRI sertraline on bone healing through pre-treatment with (10 mg·kg-1 sertraline in drinking water, n = 26) or without (control, n = 30) SSRI followed by the creation of a 5-mm calvarial defect. Animals were randomized into three surgical groups: (a) empty/sham, (b) implanted with a DermaMatrix scaffold soak-loaded with sterile PBS or (c) DermaMatrix soak-loaded with 542.5 ng BMP2. SSRI exposure continued until sacrifice in the exposed groups at 4 weeks after surgery. Sertraline exposure resulted in decreased bone healing with significant decreases in trabecular thickness, trabecular number and osteoclast dysfunction while significantly increasing mature collagen fiber formation. These findings indicate that sertraline exposure can impair bone wound healing through disruption of bone repair and regeneration while promoting or defaulting to scar formation within the defect site.

UR - http://www.scopus.com/inward/record.url?scp=85054441851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054441851&partnerID=8YFLogxK

U2 - 10.1038/s41368-018-0026-x

DO - 10.1038/s41368-018-0026-x

M3 - Article

C2 - 30174329

AN - SCOPUS:85054441851

VL - 10

JO - International journal of oral science

JF - International journal of oral science

SN - 1674-2818

IS - 3

M1 - 25

ER -